Medicare Enrolled

Dr. Samuel Pegram, MD

Rheumatology · Georgetown, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
3316 WILLIAMS DR STE 150, Georgetown, TX 78628
5122444272
Registered in NPPES since 2005
NPI: 1528043130 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Pegram from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pegram? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Pegram

Dr. Samuel Pegram is a rheumatology specialist in Georgetown, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Pegram performed 50,476 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Pegram received a total of $18,474 from 52 pharmaceutical and/or device companies across 1021 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Pegram is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ Top 23% volume in TX $18,474 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
50,476
Medicare services
Top 23% in TX for rheumatology
Not available
Unique patients (not deduplicated)
$5
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Certolizumab injection (Cimzia)
An injection of certolizumab pegol administered under the direct supervision of a physician.
49,200 $4 $19
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
280 $10 $41
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
255 $86 $380
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
227 $1 $10
Zoledronic acid injection, 1 mg
An injection of zoledronic acid administered at a dose of 1 mg.
155 $6 $29
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
62 $45 $210
Viscosupplementation injection for joint
An injection of hyaluronic acid or a derivative into a joint to provide lubrication and cushioning.
51 $59 $258
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
48 $63 $267
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
47 $40 $164
Ultrasound-guided large joint aspiration or injection
This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint.
42 $92 $289
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
29 $105 $490
Drug screening test
A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample.
28 $61 $600
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
23 $52 $187
Definitive drug test using GC/MS or LC/MS
A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS.
15 $226 $750
Definitive drug test using GC/MS or LC/MS
A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS.
14 $195 $600
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
0.1% high complexity
99.0% medium
0.9% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$18,474
Total received (2018-2024)
Avg $2,639/year across 7 years
Top 19% in TX for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
52
Companies
1,021
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,853
2023
$3,840
2022
$4,027
2021
$2,202
2020
$1,001
2019
$1,775
2018
$1,775

Payments by company (2024)

Aurinia Pharma U.S., Inc.
$608
Amgen Inc.
$463
ABBVIE INC.
$342
Novartis Pharmaceuticals Corporation
$306
Boehringer Ingelheim Pharmaceuticals, Inc.
$292
Janssen Biotech, Inc.
$275
PFIZER INC.
$253
UCB, Inc.
$231
Mallinckrodt Hospital Products Inc.
$222
AstraZeneca Pharmaceuticals LP
$195
GlaxoSmithKline, LLC.
$159
Abbott Laboratories
$156
Lilly USA, LLC
$94
E.R. Squibb & Sons, L.L.C.
$88
ANI Pharmaceuticals, Inc.
$76
Organon Llc
$34
Alexion Pharmaceuticals, Inc.
$30
Alnylam Pharmaceuticals Inc.
$30
Top 3 companies account for 36.7% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$2,825
Aurinia Pharma U.S., Inc.
$1,496
UCB, Inc.
$1,418
Janssen Biotech, Inc.
$1,248
ABBVIE INC.
$1,187
PFIZER INC.
$1,181
Horizon Therapeutics plc
$1,073
AstraZeneca Pharmaceuticals LP
$918
Mallinckrodt Hospital Products Inc.
$856
Boehringer Ingelheim Pharmaceuticals, Inc.
$820
Novartis Pharmaceuticals Corporation
$772
AbbVie, Inc.
$454
Abbott Laboratories
$446
GlaxoSmithKline, LLC.
$403
AbbVie Inc.
$383
Genentech USA, Inc.
$362
Exeltis, USA Inc.
$281
ANI Pharmaceuticals, Inc.
$262
Horizon Pharma plc
$260
Radius Health, Inc.
$259
Lilly USA, LLC
$214
GENZYME CORPORATION
$146
Celgene Corporation
$139
Antares Pharma, Inc.
$125
Mallinckrodt Enterprises LLC
$124
E.R. Squibb & Sons, L.L.C.
$117
Mallinckrodt LLC
$75
Alexion Pharmaceuticals, Inc.
$56
Actelion Pharmaceuticals US, Inc.
$51
Arbor Pharmaceuticals, Inc.
$44
RedHill Biopharma Inc.
$40
MEDEXUS PHARMA, INC.
$39
Astellas Pharma US Inc
$38
Organon Llc
$34
ARBOR PHARMACEUTICALS, INC.
$31
Alnylam Pharmaceuticals Inc.
$30
SI-BONE, Inc.
$24
Biohaven Pharmaceuticals, Inc.
$23
Alkermes, Inc.
$21
West-Ward Pharmaceuticals
$20
United Therapeutics Corporation
$20
SANOFI-AVENTIS U.S. LLC
$19
UPSHER-SMITH LABORATORIES LLC
$19
Organon LLC
$17
Takeda Pharmaceuticals U.S.A., Inc.
$17
Assertio Therapeutics, Inc.
$15
Janssen Pharmaceuticals, Inc
$14
Collegium Pharmaceutical, Inc.
$14
Forte Bio-Pharma LLC
$14
Sandoz Inc.
$13
MEDAC PHARMA, INC.
$11
GRT US Holding, Inc.
$11
Top 3 companies account for 31.1% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ANORO · AVSOLA · Actemra · Aimovig · BENLYSTA · Bimzelx · COSENTYX · CYLTEZO · Cimzia · DUEXIS · EVENITY · Enbrel · GIVLAARI · HADLIMA · HUMIRA · Horizant · Humira · KEVZARA · KRYSTEXXA · LUPKYNIS · LYRICA · MYRBETRIQ · Mitigare · Movantik · NURTEC ODT · Nucynta · OCTRODE · OFEV · OPSUMIT · ORENCIA · OTREXUP · Otezla · Otrexup · PENNSAID · PROCLAIM · PROLATE · PURIFIED CORTROPHIN GEL · Prolia · Qutenza · RAYOS · REMICADE · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI ARIA · SKYRIZI · STELARA · TALTZ · TAVNEOS · TOSYMRA · TREMFYA · TYVASO · Tymlos · UBRELVY · Uloric · VIMOVO · Vivitrol · XARELTO · XELJANZ · Zipsor
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a rheumatology specialist in Georgetown?
Compare rheumatologists in the Georgetown area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists in nearby ZIP areas
14
County median income
$108,309
Nearest hospital to ZIP centroid (approximate)
ROUND ROCK MEDICAL CENTER
9.3 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Pegram is a mixed practice specialist, with above-average Medicare volume (top 23% in TX), with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Pegram experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Pegram performed 49,200 certolizumab injection (cimzia) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Pegram receive payments from pharmaceutical companies?
Yes. Dr. Pegram received a total of $18,474 from 52 companies across 1,021 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Pegram's costs compare to other rheumatologists in Georgetown?
Dr. Pegram's average Medicare payment per service is $5. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Pegram) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →